According to a report in London’s Daily Express ...
LEADING cancer experts were furious last night after yet another drug to extend the lives of patients (Nexavar) was refused on the NHS.
The decision by the Government's drugs rationing body NICE means patients with advanced liver cancer are the only ones in Europe not to have access to the sole treatment that could help them.
In some cases, the drug can enable sufferers to live for several years. Experts said there is no good reason why the hundreds of people who require the treatment should be denied the drug.
Their outrage was further fuelled yesterday by the disclosure that one NHS Trust is offering a £22,000-a-year salary to someone to remove hairs from transgender males who want to appear more feminine.
Karol Sikora, professor of cancer medicine and medical director of CancerPartnersUK said: "Today's decision is yet another kick in the teeth for patients, their families and the medical community.
The full Daily Express story can be found here:
